Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + Cisplatin + HDFL in Advanced Gastric Cancer
NCT00632268Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Feb 2008
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in gastric cancer (GC), sponsored by National Taiwan University Hospital. Started Feb 2008; status: completed.
02
Drugs
everolimus
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00632268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632268.